The Trump administration’s claim that its TrumpRx website offers the “world’s lowest prices” on prescription drugs does not hold up against international comparisons, according to a March 18 review by The New York Times and German media partners.
TrumpRx launched in February with a list of 43 prescription medications. The Times compared prices for 24 of those drugs with those paid by Germany’s public health insurance system. In more than half of the comparisons, German prices were lower. For patent-protected drugs, the gap was most significant, with some TrumpRx prices exceeding Germany’s by thousands of dollars per month. For example, the hormone treatment Ngenla costs American families $2,700 more monthly.
While TrumpRx prices appeared more competitive for some generic drugs, analysts noted that Germany’s actual prices may be even lower after undisclosed discounts are applied. The administration said TrumpRx prices were based on comparisons with eight countries: Canada, France, Germany, Italy, Japan, the U.K., Switzerland and Denmark. But pharmacy visits in those nations showed Americans still pay more for high-demand weight-loss medications such as Wegovy and Zepbound, even after recent U.S. price cuts.
Meanwhile, a separate March 18 report by NBC News highlighted broader shortcomings of the platform. TrumpRx currently lists 54 medications, many of which have cheaper generic versions or existing discount options elsewhere. The site does not support insurance, direct purchasing or deductible integration. Survey data showed 7% of U.S. adults who take prescription drugs have visited the site, rising to 16% among GLP-1 users.
White House officials and drugmakers argued that international price comparisons should consider local wages and economic conditions. But health policy analysts said the administration’s pricing claims are misleading without clearer transparency, broader access and structural reforms to improve utility for most consumers.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.